World Hematology 2019

We welcome all to join us at World Hematology 2019 on July 24- 25, 2019 at Rome, Italy. We have our Speaker slots open!! Do submit your abstracts and register Soon!! We provide special offers on Group Registrations! For more details, PS: https://hematology.cmesociety.com/

For details, do contact : Vijaya | Program Manager | World Hematology 2019 | worlhematology@pulsusevents.net

A cancer biomarker refers to a substance which indicates the presence of cancer in the body and are particularly associated with genetic mutations or epigenetic alterations which determine whether the individuals are susceptible to particular type of cancers or not.

Our Speaker/ Poster/ YRF slots are open!! Submit your abstracts now at: https://hematology.cmesociety.com/abstract-submission

Delegates, Exhibitors and Sponsors are welcome. Use the opportunity to meet and greet the experts in the field. Register soon to avail special offers at: https://hematology.cmesociety.com/registration

World Hematology 2019

Rome, Italy is all set for World Hematology 2019. Join us on July 24- 25, 2019 to unveil the mysteries in Hematology/ Oncology and enjoy the summer glow at the most populous city in Europe. Explore Hem/ Onc with experts at the most historically, educationally and culturally interesting city in the World. For more details, PS: https://hematology.cmesociety.com/ or drop us an email at: worldhematology@pulsusevents.net

World Hematology 2019

World Hematology 2019 will provide a stimulating scientific environment and a platform for the participants to exchange ideas, establish research collaboration and networking. It will be an amazing opportunity for the attendees to explore the beautiful city, at the same time, helps to gain knowledge in the field of hematology which will surely help to raise insights, conflate present with future and cogitate ideas in Hematology and Oncology.Do join us at Rome, Italy on July 24-25, 2019.

Submit your abstracts today to avail 25% discount on your registration, PS: https://hematology.cmesociety.com/abstract-submission

Track 13: Hematology & Cancer Immunology

Cancer immunology is a branch of immunology that deals with the interaction of  immune system with cancer cells (also called tumors or malignancies). It is a field of research which helps to innovate cancer immunotherapies inorder to treat and retard the progression of disease. The immune response has the capacity of recognizing cancer-specific antigens which forms the basis of targeted therapy (like vaccines & antibody therapies) and tumour marker based diagnostic tests.

Join us on July 24-25, 2019 at Rome, Italy. Do submit your abstracts and avail exciting early bird offers!! PS: https://hematology.cmesociety.com/abstract-submission

World Hematology 2019

Hurry Up!! Grab the opportunity!! Join us to unleash the conundra in Hematology/ Oncology at Rome, Italy on July 24-25, 2019. We provide special benefits for group registrations. For more details, Please visit: https://hematology.cmesociety.com/ or mail us at: worldhematology@pulsusevents.net

World Hematology 2019

Our speaker slots are open!! Submit your abstracts now & grab the opportunity to avail early bird offers on registration!! Explore Hematology/ Oncology, experiencing the beauty of Rome, Italy. Rome, Italy is all set for World Hematology 2019 scheduled during July 24- 25, 2019. To know more, PS: https://hematology.cmesociety.com/

Track 12: Pediatric Hematology and Oncology

Pediatrics or paediatrics is a branch of medicine which deals with medical care of infants, children and adolescents, the age limit usually ranges from birth up to 19 years of age (in some places until completion of secondary education). A medical practitioner who specializes in this area is called as a paediatrician. Pediatricians work as primary care physicians in neonatology. Pediatric haematologists or Pediatric oncologists diagnose, treat and manage children and teens with cancer which include leukaemia, lymphoma, brain tumour, bone tumour and other Cancers.  The hematology oncology of infancy is the current area of research where its development depend on the evolution of science of Hematology and on the study of blood and its elements. The body of an infant or neonate is physiologically different when compared to an adult. Congenital defects, genetic variance and developmental issues are some greater concerns to pediatricians when compared to other physicians.

Greet and meet renowned Hematologists and Oncologists and share your views to unveil the mysteries in the field of Hematology/ Oncology by joining us at World Hematology 2019 on July 24-25, 2019 at Rome, Italy. To submit your abstracts, PS: https://hematology.cmesociety.com/abstract-submission

To know more about registration, PS: https://hematology.cmesociety.com/registration

For more details, please drop us an e-mail at: worldhematology@pulsusevents.net

Hematology/ Oncology Conference: World Hematology 2019

Speaker slots for World Hematology 2019 are Open Now!!! Submit your abstracts today and avail 20% discounts on your registrations!! Offer valid only today!! Grab your slots now!!

For more details about sessions, Visit: https://hematology.cmesociety.com/call-for-abstracts

To know more, drop us an e-mail at: worldhematology@pulsusevents.net

Track 11: Blood Transplantation

Blood transfusion is usually defined as the process of receiving blood or blood products into one's circulation intravenously in order to replace the lost components of blood. Earlier whole blood was transfused but modern medical practice commonly uses only the components of  blood. Umbilical cord blood is an alternate source of hematopoietic stem cell for those patients who are suffering from the hematologic disease and can be cured by allogeneic hematopoietic cell transplantation. The umbilical cord conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies nutrient-rich blood from the placenta to fetus. The hematopoietic bone marrow transplant is a procedure which involves replacement of damaged bone marrow with a healthy bone marrow stem cells.
Do submit your abstracts on this track now and avail exciting early bird and group registration offers. To know more about abstract submission, PS: https://hematology.cmesociety.com/abstract-submission

To know more about registration, PS: https://hematology.cmesociety.com/registration

In case of queries, please do not hesitate to drop us an e- mail at: worldhematology@pulsusevents.net

World Hematology 2019

Unleash the conundra in Hematology/ Oncology through World Hematology 2019 at Italy by transpiring enigmas in Hematology and Oncology.

World Hematology 2019 which is to be organized on July 24- 25, 2019 at Rome, Italy has many interactive scientific sessions on different types of Blood disorders and Cancers as well as various diagnostic and therapeutic advancements in this field. It is an initiative to unite the diverse research and business communities working in this field under one roof to explore every single aspect of Oncology and Hematology. 

The conference is focussed on the following topics and sessions:

• Advancements in Hematopoietic cell transplantation
• Anticipating the development of Paediatric Hematology/ Oncology
• Recent trends in diagnosing Hematology/ Oncology indications
• Emerging trends in Cancer Care
• Therapeutic advancements and many more….

For more information about the Conference, please visit: https://hematology.cmesociety.com/

We offer special group benefits on Group registrations. Do join us and enjoy special benefits.

We have our speaker slots open!! Submit your abstracts now and avail early bird offers: https://hematology.cmesociety.com/abstract-submission

World Cancer Day 2019

Join us at World Hematology 2019 on July 24- 25, 2019 at Rome, Italy. Meet and greet the experts in field!! Share and groom your knowledge at the right platform!!

Submit your abstracts at: https://hematology.cmesociety.com/abstract-submission and avail 25% waivers on registrations: https://hematology.cmesociety.com/registration on account of World Cancer Day.

We also offer special group benefits!!

World Cancer Day

This World Cancer Day, let us all join hands in creating awareness among people about Cancers, its cause, prevention, diagnosis and treatment. Do join us at World Hematology 2019 on July 24- 25, 2019 at Rome, Italy and unleash the enigma in Hematology/ Oncology. We do provide 25% waivers on registrations for a week on account of the World Cancer Day and also provide special group registration benefits.

Do submit your abstracts and register to avail World Cancer Day benefits: https://hematology.cmesociety.com/abstract-submission  https://hematology.cmesociety.com/registration

For more details, drop us a mail and we'll get back to you: worldhematology@pulsusevents.net

Track 10 : Blood Disorders Diagnosis and Treatment

A bone marrow biopsy is done for diagnosing blood disorders. This usually includes study of chromosomes (cytogenetics) and examination of the surface proteins or receptors on the bone marrow cells through the process of flow cytometry. Treatments of blood disorders vary depending on the type of disease and may include use of steroids and other immune-modulating therapies, transfusions or coagulation factor support, growth factor supplementation, complex chemotherapy and bone marrow transplantation. Palliative care is one of the most specialised approach which provide medical care for people who suffer from serious illness. Anticoagulants (antithrombics) are a class of drugs that work to prevent the coagulation which are used in hemodialysis machine, Heart-lung machine, etc. One type of vascular filter called the vena cava filter is implanted by interventional radiologists or vascular surgeons into the inferior vena cava to prevent life-threatening pulmonary emboli with the use of ionizing radiation, generally, as part of cancer treatment to manage and control malignant cells. Most of the hematologist prefer physical examinations, medical history and laboratory testing to detect hematological diseases or disorders of the patient.

Do join us on July 23- 24, 2019 at Rome, Italy and unleash the enigma in Hematology/ Oncology.

Do submit your abstracts, PS: https://hematology.cmesociety.com/abstract-submission and book your slots at: https://hematology.cmesociety.com/registration

We do offer special offers and benefits on Group Registrations. To know more, Please do drop us a mail at: worldhematology@pulsusevents.net

Track 9: Blood Disorders

Blood is a living tissue which consists of liquid and solid. The liquid part is plasma containing water, salts and protein and the solid part containing red blood cells, white blood cells and platelets. Blood disorders affect one or more parts of the blood and can be acute or chronic. Many blood disorders are also inherited. Haemophilia A is a genetic disorder with the deficiency of clotting factor VIII. The second-most common form of haemophilia is Hemophilia B, a blood clotting disorder caused by mutation of the factor IX gene, leading to deficiency in its factor IX. Rare haemophilia is Hemophilia C which affects both male and female. However, it most commonly occurs in Jews of Ashkenazi descendants which is also most famously known as fourth coagulation disorder after von Willebrand's disease and haemophilia A and B.

In USA, it is thought to affect 1 in 100,000 of the adult population. Idiopathic thrombocytopenic purpura (ITP) is defined as isolated low platelet count (thrombocytopenia) with normal bone marrow and absence of other causes of thrombocytopenia. It is also known as immune thrombocytopenia or primary immune thrombocytopenia or primary immune thrombocytopenic purpura or autoimmune thrombocytopenic purpura. The most common disease described in humans is Von Willebrand disease which is a hereditary coagulation abnormality. Platelets are also known as "thrombocytes" and its function (along with the coagulation factors) is to stop bleeding by clumping and clogging blood preventing blood vessel injuries.

Explore more about Hematology at World Hematology 2019. Do submit your abstracts on this track at: https://hematology.cmesociety.com/abstract-submission

We do provide exciting offers on group registrations. Join us with a group and avail special offers!!

For more information, Please Contact: Vijaya | Program Manager | worldhematology@pulsusevents.net

World Hematology 2019

Submit your abstracts and avail discounts and early bird pricing. We do offer exciting discounts on group registrations. Unleash the mysteries behind Hematology/Oncology at the most historically, educationally and culturally interesting city in the World: Rome, Italy on July 23-24,2019.

Abstract details: https://hematology.cmesociety.com/abstract-submission

Email: worldhematology@pulsusevents.net

Cancer Diagnosis and Treatment

#Cancers are recognized due to the #signs or #symptoms that occur after a particular #stage or through #screening. Neither of these leads to exact #diagnosis of the #disease and its type, it mainly requires examination of a #tissue sample obtained generally by #biopsy, by a #pathologist. #Cancer can be treated by many methods such as #surgery, #chemotherapy, #hormonal_therapy, #radiation_therapy, #targeted_therapy and #synthetic lethality. People suffering from #Cancer can be investigated through #medical_tests which includes #blood_tests, #X-rays, #CT_scans and #endoscopy. The #tissue #diagnosis from the #biopsy indicates the type of #cell that proliferates through its #histological grade, #genetic_abnormalities and other features.  All together it gives useful information about the #molecular changes such as #mutations, #fusion #genes and numerical #chromosome to estimate  the #prognosis inorder to choose the best #treatment. #Cytogenetics and #immunohistochemistry are the other common #tissue #tests. The removal of #cancer without damaging the other parts of the #body (by achieving cure with near-zero adverse effects) is the main goal of the #treatment. The type of #treatment depends on the type of #cancer the #patient is suffering from and its #stage. Most of the people with #Cancer have a combination of #treatments such as #surgery with #chemotherapy or #radiation_therapy, #Immunotherapy, #targeted_therapy or #hormone_therapy.

Explore new trends in #Cancer #diagnosis and #treatment at World Hematology 2019 on July 23-24, 2019 at #Rome, #Italy, PS: https://hematology.cmesociety.com/call-for-abstracts

Track 7: Cancer Genomics & Metabolomics

#Oncogenomics is a field in #genomics which characterize #cancer-associated  #genes. Its main focus includes #genomic, #epigenomic and #transcript #alterations in #cancer. The main concept and idea of #oncogenomics is to check new group of #oncogenes or #tumour_suppressor_genes that may give new areas of #research into #cancer_diagnosis, predicting #clinical outcome of #cancer_treatment and new #targets for #cancer_therapies. The #Gleevec, #Herceptin and #Avastin are the targeted #cancer_therapies which gave a new way for #oncogenomics to elucidate new targets for #cancer_treatment. #Metabolomics is a newly emerging field in 'omics' #research and refers to the complete set of small-molecule #metabolites, which gives the systematic study of unique chemical #fingerprints that leaves #cellular processes behind. The #metabolome represents the collection of all #metabolites in a #biological_cell, #tissue, #organ or an #organism that are the end products of #cellular_processes. #Metabolic_profiling gives an instantaneous snapshot of the #physiology of given #cell. One of the challenging aspects of system #biology and functional #genomics is to integrate #proteomic, #transcriptomic and #metabolomic information which provide a better understanding of #cellular #biology.

Explore more about #Hematology_Oncology and unleash the enigma in #Hematology and #Oncology through #WorldHematology2019 on #July 23- 24, 2019 at #Rome, #Italy #Hematology_Conferences, #Cancer_Conferences, #Oncology_Conferences, #Blood_Conferences, #Blood_Disorders_Conferences, #Internal_medicine_Conferences, #Cancer_research_Conferences, #Pulsus_Conferences

To know more about #tracks and #abstract_submission, PS: https://hematology.cmesociety.com/abstract-submission

Track 6:

Medical Oncology is the type of cancer treatment where drugs are used to destroy cancer cells. Medical Oncologist’s purpose is to deliver the best outcome for cancer patients providing palliative care. Chemotherapy uses anti-cancer drug stopping the growth of cancer cells. It also harms the cells which are healthy such as those that line the mouth and intestines. Side effects generally occur while dispensing Chemotherapy. So neoadjuvant therapy can be given before surgery to reduce the risks. Clinical Oncology is the sort of Cancer treatment in which doctors use Chemotherapy as well as Radiotherapy to treat patients. Technologies are nowadays developing rapidly in the field of Clinical Oncology, for example: some tumours can be treated with highly sophisticated external beam radiation therapy such as Proton beam therapy.

Do submit your abstracts and avail exciting offers. For more details, Please visit: https://hematology.cmesociety.com/

Track 5: Surgical Oncology

#Surgical_oncology comes under the field of #surgery applied to #oncology, which involves the #surgical_management of #tumours, mainly #cancerous_tumours. The goals of the #surgical_oncologist includes the removal of #cancerous_cells and keeping an area of #healthy_tissue surrounding it, also known as a clear margin or clear excision in order to prevent the #cancer recurring in that area. Sometimes it's difficult to remove the whole #tumor, therefore, a debulking #surgery can be done to remove as much #tumour as possible and to relieve #symptoms such as #pain, #airway_obstruction and #bleeding. #Surgical_oncologists are also called as general surgical oncologists, #thoracic_surgical_oncologists, subspecialty of general surgery, #gynecologic_oncologists, etc who are experienced  in treating  the #cancer_patients. The James Ewing Society is recognised today as the Society of Surgical Oncology which was started by the surgeons interested in initiating and promoting the field of #oncology. Complex General Surgical Oncology was given by American Board of Surgery, specially ratified as specialty Board certification in the year 2011.

Do submit your abstracts and explore more about #Hematology_Oncology!!

We also provide special group discounts!!

For more info, Please do visit: https://hematology.cmesociety.com/

 Contact: Vijaya L

Program Manager | World Hematology 2019

worldhematology@pulsusmeet.com | worldhematology@pulsusevents.net